SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC
NCT07451795
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Interventions
COMBINATION_PRODUCT:
SHR-1701 + SBRT
RADIATION:
SBRT
Sponsor
Fudan University